Dulac Edward J Iii

EDGAR CIK 0001821530

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($104,617)
-7,462 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/23/2025
07/25/2025
Sell
-7,462 @ $14.02
 ($104,617) 106,062 (-6.57%) Direct